We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $3.51B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
-0.73%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$3.51B
AUM Growth
+$30.4M
Cap. Flow
+$70M
Cap. Flow %
1.99%
Top 10 Hldgs %
63.99%
Holding
355
New
36
Increased
103
Reduced
149
Closed
17

Top Buys

1
VBR icon
Vanguard Small-Cap Value ETF
VBR
+$26.6M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$23.2M
3
IUSV icon
iShares Core S&P US Value ETF
IUSV
+$10.6M
4
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$6.64M
5
ACWV icon
iShares MSCI Global Min Vol Factor ETF
ACWV
+$3.92M

Top Sells

1
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$3.54M
2
AAPL icon
Apple
AAPL
+$3M
3
MSFT icon
Microsoft
MSFT
+$2.43M
4
IWV icon
iShares Russell 3000 ETF
IWV
+$1.8M
5
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$1.61M

Sector Composition

1 Technology 3.46%
2 Financials 2.08%
3 Communication Services 1.14%
4 Healthcare 0.74%
5 Industrials 0.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HPQ icon
326
HP
HPQ
$22.7B
$215K 0.01%
+11,203
New +$218K
AVUV icon
327
Avantis US Small Cap Value ETF
AVUV
$29.4B
$213K 0.01%
1,931
-438
-18% -$48.2K
APD icon
328
Air Products & Chemicals
APD
$65.8B
$213K 0.01%
+734
New +$202K
URTH icon
329
iShares MSCI World ETF
URTH
$8.04B
$212K 0.01%
1,176
-121
-9% -$22.6K
ALL icon
330
Allstate
ALL
$64.3B
$210K 0.01%
+1,013
New +$208K
CTVA icon
331
Corteva
CTVA
$58.4B
$210K 0.01%
+2,508
New +$189K
IRM icon
332
Iron Mountain
IRM
$36.8B
$209K 0.01%
+2,043
New +$203K
CI icon
333
Cigna
CI
$74.5B
$207K 0.01%
775
-66
-8% -$18.3K
TXT icon
334
Textron
TXT
$15.9B
$202K 0.01%
+2,304
New +$215K
GUNR icon
335
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$6.98B
$200K 0.01%
+3,633
New +$190K
XERS icon
336
Xeris Biopharma Holdings
XERS
$1.52B
$116K ﹤0.01%
20,000
– –
ABEV icon
337
Ambev
ABEV
$46.8B
$73K ﹤0.01%
25,000
-148
-0.6% -$423
UA icon
338
Under Armour Class C
UA
$3.1B
$57.9K ﹤0.01%
+10,000
New +$63.1K
ANET icon
339
Arista Networks
ANET
$212B
– –
-2,353
Closed -$308K
BN icon
340
Brookfield
BN
$107B
– –
-20,846
Closed -$957K
COR icon
341
Cencora
COR
$59.9B
– –
-603
Closed -$204K
DOCU
342
DocuSign
DOCU
$10.1B
– –
-6,183
Closed -$423K
FROG icon
343
JFrog
FROG
$10.7B
– –
-8,595
Closed -$537K
ICE icon
344
Intercontinental Exchange
ICE
$79B
– –
-1,650
Closed -$267K
ILCG icon
345
iShares Morningstar Growth ETF
ILCG
$3.12B
– –
-3,614
Closed -$376K
INTU icon
346
Intuit
INTU
$79.6B
– –
-317
Closed -$210K
IYW icon
347
iShares US Technology ETF
IYW
$24B
– –
-1,043
Closed -$208K
KKR icon
348
KKR & Co
KKR
$90.6B
– –
-1,592
Closed -$203K
NOW icon
349
ServiceNow
NOW
$106B
– –
-3,135
Closed -$480K
NVO
350
Novo Nordisk
NVO
$223B
– –
-4,941
Closed -$251K
11 12 13
14
15

Similar funds

BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.51B AUM 39.24% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
KCM
Kedalion Capital Management London, United Kingdom $3.48B AUM 17.74% 1-Year Est. Return

Aspiriant LLC's Q1 2026 Portfolio in Review

As of Q1 2026, Aspiriant LLC held 355 positions worth $3.51B, up 0.87% from $3.48B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Aspiriant LLC's Q1 2026 filing shows 36 new, 103 increased, 149 reduced and 17 closed positions. Its largest new stake was Rhythm Pharmaceuticals: 33,007 shares worth $2.87M. The largest sale was Vanguard Tax-Exempt Bond Index Fund, an estimated $3.54M.

By sector, the portfolio is most concentrated in Technology at 3.5% of assets, down from 4.1% a quarter earlier, followed by Financials and Communication Services.

  • Aspiriant LLC's largest Q1 2026 buy was Rhythm Pharmaceuticals: 33,007 shares worth $2.87M.
  • Aspiriant LLC added most to Vanguard Small-Cap Value ETF in Q1 2026, an estimated $26.6M increase.
  • Aspiriant LLC's biggest Q1 2026 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $3.54M.
  • Aspiriant LLC fully exited Brookfield in Q1 2026, selling an estimated $957K.
  • Aspiriant LLC's ten largest holdings make up 64% of its $3.51B portfolio in Q1 2026.
  • Aspiriant LLC opened 36 new positions and closed 17 in Q1 2026.
  • Aspiriant LLC's portfolio value rose 0.87% quarter-over-quarter to $3.51B.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.